Mendel Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
5,227
+7
+0.1% +$2.4K 0.85% 25
2026
Q1
$1.84M Buy
+5,220
New +$1.86M 0.92% 25
2025
Q3
$1.44M Buy
5,089
+130
+3% +$37.7K 0.75% 35
2025
Q2
$1.38M Buy
4,959
+7
+0.1% +$1.98K 0.79% 30
2025
Q1
$1.54M Buy
4,952
+151
+3% +$44.6K 0.93% 25
2024
Q4
$1.25M Buy
4,801
+199
+4% +$59K 0.76% 32
2024
Q3
$1.48M Buy
4,602
+45
+1% +$14.7K 0.91% 25
2024
Q2
$1.42M Sell
4,557
-60
-1% -$17.6K 0.92% 23
2024
Q1
$1.31M Sell
4,617
-275
-6% -$80.5K 0.87% 26
2023
Q4
$1.41M Buy
4,892
+44
+0.9% +$12K 1.01% 21
2023
Q3
$1.3M Sell
4,848
-33
-0.7% -$8.23K 1.07% 23
2023
Q2
$1.08M Buy
4,881
+53
+1% +$12.3K 0.87% 26
2023
Q1
$1.17M Buy
4,828
+203
+4% +$49.8K 1.05% 18
2022
Q4
$1.21M Buy
4,625
+52
+1% +$13.9K 1.27% 18
2022
Q3
$1.03M Buy
4,573
+426
+10% +$103K 1.21% 17
2022
Q2
$1.01M Sell
4,147
-86
-2% -$21.1K 1.13% 18
2022
Q1
$1.02M Buy
4,233
+497
+13% +$114K 0.97% 21
2021
Q4
$840K Buy
+3,736
New +$789K 0.77% 25

Other funds holding AMGN

Mendel Capital Management's AMGN Position: Q2 2026 in Review

Mendel Capital Management increased its Amgen (AMGN) stake by 0.13% in Q2 2026, buying an estimated $2.4K and bringing the position to 5,227 shares worth $1.89M. The position accounts for 0.85% of the portfolio, ranked #25.

Mendel Capital Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mendel Capital Management held 5,227 shares of Amgen worth $1.89M as of Q2 2026.
  • Mendel Capital Management bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.85% of Mendel Capital Management's portfolio in Q2 2026, its #25 holding.
  • Mendel Capital Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mendel Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.